Mutant FUS and ELAVL4 (HuD) Aberrant Crosstalk in Amyotrophic Lateral Sclerosis. Academic Article uri icon

Overview

abstract

  • Amyotrophic lateral sclerosis (ALS) has been genetically linked to mutations in RNA-binding proteins (RBPs), including FUS. Here, we report the RNA interactome of wild-type and mutant FUS in human motor neurons (MNs). This analysis identified a number of RNA targets. Whereas the wild-type protein preferentially binds introns, the ALS mutation causes a shift toward 3' UTRs. Neural ELAV-like RBPs are among mutant FUS targets. As a result, ELAVL4 protein levels are increased in mutant MNs. ELAVL4 and mutant FUS interact and co-localize in cytoplasmic speckles with altered biomechanical properties. Upon oxidative stress, ELAVL4 and mutant FUS are engaged in stress granules. In the spinal cord of FUS ALS patients, ELAVL4 represents a neural-specific component of FUS-positive cytoplasmic aggregates, whereas in sporadic patients it co-localizes with phosphorylated TDP-43-positive inclusions. We propose that pathological mutations in FUS trigger an aberrant crosstalk with ELAVL4 with implications for ALS.

publication date

  • June 25, 2019

Research

keywords

  • Amyotrophic Lateral Sclerosis
  • Cytoplasm
  • ELAV-Like Protein 4
  • Mutation
  • RNA-Binding Protein FUS

Identity

PubMed Central ID

  • PMC6613039

Scopus Document Identifier

  • 85067263880

Digital Object Identifier (DOI)

  • 10.1016/j.celrep.2019.05.085

PubMed ID

  • 31242416

Additional Document Info

volume

  • 27

issue

  • 13